Advanced
  Home Compare Reports

Comparison with Similar Reports

Track and Trace Solutions Market by Product (Plant Manager, Checkweigher, Barcode Scanner, Monitoring), Technology (2D Barcode, RFID), Application (Se...

Publisher:        MarketsandMarkets

# of Pages:        320

Rating: 

1 User License $4,950

Publication Date:  May, 2021

Price:       $4,950 / User License




1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.2.2 MARKETS COVERED 30
1.2.3 YEARS CONSIDERED FOR THE STUDY 31
1.3 CURRENCY 31
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 31
1.4 LIMITATIONS 31
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
2.1.2.2 Insights from primary experts 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (TRACK AND TRACE SOLUTIONS MARKET) 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION: TRACK AND TRACE SOLUTIONS MARKET 40
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: TOP 12 PLAYERS (HARDWARE SYSTEMS AND STANDALONE PLATFORMS) 42
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION –HARDWARE SYSTEMS AND STANDALONE PLATFORMS 43
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
FIGURE 9 TOP-DOWN APPROACH 45
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46
FIGURE 10 DATA TRIANGULATION METHODOLOGY 46
2.4 MARKET SHARE ANALYSIS 47
2.5 ASSUMPTIONS FOR THE STUDY 47
 
2.6 RISK ASSESSMENT 48
TABLE 2 RISK ASSESSMENT: TRACK AND TRACE SOLUTIONS MARKET 48
2.7 COVID-19 HEALTH ASSESSMENT 48
2.8 COVID-19 ECONOMIC ASSESSMENT 48
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 49
FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY 49
FIGURE 12 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 50
3 EXECUTIVE SUMMARY 51
FIGURE 13 TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 51
FIGURE 14 TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 52
FIGURE 15 TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 52
FIGURE 16 TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 53
FIGURE 17 TRACK AND TRACE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT 54
4 PREMIUM INSIGHTS 55
4.1 TRACK AND TRACE SOLUTIONS MARKET OVERVIEW 55
FIGURE 18 STRINGENT REGULATIONS & STANDARDS FOR THE IMPLEMENTATION OF SERIALIZATION IS A MAJOR FACTOR DRIVING THE MARKET GROWTH 55
4.2 ASIA PACIFIC: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY AND COUNTRY (2020) 56
FIGURE 19 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 56
4.3 TRACK AND TRACE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
FIGURE 20 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 57
4.4 REGIONAL MIX: TRACK AND TRACE SOLUTIONS MARKET (2021−2026) 58
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE TRACK AND TRACE SOLUTIONS MARKET DURING THE FORECAST PERIOD 58
4.5 TRACK AND TRACE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS 58
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS 59
5.2.1 DRIVERS 60
5.2.1.1 Stringent regulations & standards for the implementation of serialization 60
TABLE 4 SERIALIZATION & AGGREGATION REGULATIONS, BY COUNTRY/REGION 60
5.2.1.2 Increasing focus of manufacturers on brand protection 62
5.2.1.3 Growth in the number of packaging-related product recalls 62
FIGURE 23 NUMBER OF MEDICAL DEVICE RECALLS, 2013–2017 63
5.2.1.4 High growth in the generic and OTC markets 63
FIGURE 24 GROWTH OF THE GENERICS MARKET, 2006 VS. 2016 64
FIGURE 25 GLOBAL OTC PHARMACEUTICALS MARKET, 2020 (USD BILLION) 65
5.2.1.5 Growth in the medical device industry 65
FIGURE 26 MEDICAL DEVICE MARKET, 2016–2020 (USD BILLION) 66
5.2.2 RESTRAINTS 66
5.2.2.1 Huge setup costs 66
5.2.2.2 High costs and long implementation timeframe associated with serialization and aggregation 66
5.2.3 OPPORTUNITIES 67
5.2.3.1 Increase in offshore pharmaceutical manufacturing 67
FIGURE 27 PHARMACEUTICAL IMPORTS AND EXPORTS, BY COUNTRY, 2019 (USD BILLION) 67
5.2.3.2 Remote authentication of products 68
5.2.3.3 Technological advancements 68
5.2.3.4 Growth in the food traceability market 68
5.2.4 CHALLENGES 69
5.2.4.1 Lack of common standards for serialization and aggregation 69
5.2.4.2 Existence of technologies that deter counterfeiters 70
6 INDUSTRY INSIGHTS 71
6.1 INTRODUCTION 71
6.2 INDUSTRY TRENDS 71
6.2.1 RISING DEMAND FOR INTEGRATED FULLY AUTOMATED SERIALIZATION AND AGGREGATION SYSTEMS 71
6.2.2 INCREASING CONSOLIDATION AMONG MARKET PLAYERS 72
6.2.3 USE OF BLOCKCHAIN IN TRACK AND TRACE SOLUTIONS 72
6.3 TECHNOLOGY ANALYSIS 73
6.3.1 GROWING DEMAND FOR L4 AND L5 TRACK AND TRACE SOLUTIONS IN THE PHARMACEUTICAL INDUSTRY FOR COMPLIANCE MANAGEMENT 73
FIGURE 28 TRACK AND TRACE SOLUTIONS OFFERED BY VENDORS, BY LEVEL 75
6.4 GLOBAL PHARMACEUTICAL AND FOOD TRACK AND TRACE SOLUTIONS MARKET: PENETRATION AND OPPORTUNITY 75
FIGURE 29 PENETRATION AND OPPORTUNITIES IN THE PHARMACEUTICAL TRACK AND TRACE SOLUTIONS MARKET, 2021 VS. 2026 76
TABLE 5 NUMBER OF SERIALIZATION AND AGGREGATION SOLUTION INSTALLATIONS, BY COMPANY 76
6.5 REGULATORY ANALYSIS 76
FIGURE 30 TRACK AND TRACE SOLUTIONS MARKET: REGULATORY TIMELINES, BY COUNTRY 77
 
6.5.1 NORTH AMERICA 78
TABLE 6 NORTH AMERICA: SERIALIZATION AND E-PEDIGREE REGULATIONS FOR THE PHARMACEUTICAL INDUSTRY 78
TABLE 7 US: UDI REGULATIONS FOR MEDICAL DEVICES 79
6.5.2 EUROPE 79
TABLE 8 EUROPE: SERIALIZATION REGULATIONS FOR THE PHARMACEUTICAL INDUSTRY 79
TABLE 9 EUROPE: REGULATIONS FOR UDI SYSTEM COMPLIANCE 80
6.5.3 ASIA PACIFIC 80
TABLE 10 ASIA PACIFIC: SERIALIZATION REGULATIONS FOR THE PHARMACEUTICAL INDUSTRY 80
6.5.4 LATIN AMERICA AND THE MIDDLE EAST & AFRICA 81
TABLE 11 LATIN AMERICA AND THE MIDDLE EAST & AFRICA: SERIALIZATION REGULATIONS FOR THE PHARMACEUTICAL INDUSTRY 81
6.6 STRATEGIC BENCHMARKING 81
TABLE 12 TRACK AND TRACE SOLUTIONS PORTFOLIO ANALYSIS 82
6.7 VALUE CHAIN ANALYSIS 83
FIGURE 31 TRACK AND TRACE SOLUTIONS MARKET: VALUE CHAIN ANALYSIS 83
6.8 END-USER DEMAND ANALYSIS 84
6.8.1 DEMAND ANALYSIS FOR TRACK AND TRACE SOLUTIONS 84
6.8.2 UNMET NEEDS 84
6.8.3 CHALLENGES ASSOCIATED WITH MANUAL TRACK AND TRACE OF PRODUCTS: END-USER PERSPECTIVE 84
6.9 ECOSYSTEM ANALYSIS 85
TABLE 13 TRACK AND TRACE SOLUTIONS MARKET: ECOSYSTEM MAPPING 85
FIGURE 32 TRACK AND TRACE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 86
6.10 PORTER’S FIVE FORCES ANALYSIS 86
TABLE 14 PORTER’S FIVE FORCES ANALYSIS 87
6.11 COVID-19 IMPACT ON THE TRACK AND TRACE SOLUTIONS MARKET 89
6.12 PATENT ANALYSIS 90
TABLE 15 PHARMA, FOOD, AND MEDICAL DEVICE-RELATED PACKAGING OF TRACK AND TRACE SOLUTIONS AND THEIR PATENT YEARS 90
6.13 PRICING ANALYSIS 91
7 TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT 93
7.1 INTRODUCTION 94
TABLE 16 TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 94
7.2 SOFTWARE 94
TABLE 17 TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 94
TABLE 18 TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
 
7.2.1 PLANT MANAGERS 95
7.2.1.1 Growing awareness of secure packaging and strict regulations to drive market growth 95
TABLE 19 PLANT MANAGERS OFFERED BY KEY MARKET PLAYERS 96
TABLE 20 PLANT MANAGERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 96
7.2.2 ENTERPRISE & NETWORK MANAGERS 97
7.2.2.1 Mandates for the reporting of product information to regulatory authorities are expected to drive market growth 97
TABLE 21 ENTERPRISE & NETWORK MANAGERS OFFERED BY KEY MARKET PLAYERS 97
TABLE 22 ENTERPRISE & NETWORK MANAGERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 98
7.2.3 LINE CONTROLLERS 98
7.2.3.1 Increasing need to improve supply chain efficiency in various industries is driving market growth 98
TABLE 23 LINE CONTROLLERS OFFERED BY KEY MARKET PLAYERS 99
TABLE 24 LINE CONTROLLERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
7.2.4 BUNDLE TRACKING SOLUTIONS 100
7.2.4.1 Bundle tracking software offers accuracy in serialization and identification—a key factor driving market growth 100
TABLE 25 BUNDLE TRACKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 100
TABLE 26 BUNDLE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
7.2.5 CASE TRACKING SOLUTIONS 101
7.2.5.1 Case trackers offer accurate serialization of the case to ensure its traceability throughout the supply chain—a key factor driving market growth 101
TABLE 27 CASE TRACKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 101
TABLE 28 CASE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
7.2.6 WAREHOUSE & SHIPMENT MANAGERS 102
7.2.6.1 Warehouse & shipment managers manage order receipts from the ERP and shipment operations 102
TABLE 29 WAREHOUSE & SHIPMENT MANAGERS OFFERED BY KEY MARKET PLAYERS 102
TABLE 30 WAREHOUSE & SHIPMENT MANAGERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
7.2.7 PALLET TRACKING SOLUTIONS 103
7.2.7.1 Pallet tracking solutions are used for the identification and verification of pallets throughout the supply chain 103
TABLE 31 PALLET TRACKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 103
TABLE 32 PALLET TRACKING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
7.3 HARDWARE COMPONENTS 104
TABLE 33 TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 34 TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
 
7.3.1 PRINTING & MARKING SOLUTIONS 106
7.3.1.1 This segment held the largest share of the market and is also estimated to grow at the highest cagr 106
TABLE 35 PRINTING & MARKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS 106
TABLE 36 PRINTING & MARKING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
7.3.2 BARCODE SCANNERS 108
7.3.2.1 Rising need for anti-counterfeiting technologies and increasing awareness of patient safety are the key driving factors this segment 108
TABLE 37 BARCODE SCANNERS OFFERED BY KEY MARKET PLAYERS 108
TABLE 38 BARCODE SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 109
7.3.3 MONITORING & VERIFICATION SOLUTIONS 109
7.3.3.1 Optical character recognition and optical character verification camera systems are used to verify serial numbers and code sets 109
TABLE 39 MONITORING & VERIFICATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 110
TABLE 40 MONITORING & VERIFICATION SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
7.3.4 LABELERS 111
7.3.4.1 The pharmaceutical industry is focusing on implementing anti-counterfeiting measures and making labels tamper-evident 111
TABLE 41 LABELERS OFFERED BY KEY MARKET PLAYERS 111
TABLE 42 LABELERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
7.3.5 CHECKWEIGHERS 113
7.3.5.1 Checkweighers offer a means of automatically tracking products from the point-of-code verification to a reject mechanism 113
TABLE 43 CHECKWEIGHERS OFFERED BY KEY MARKET PLAYERS 113
TABLE 44 CHECKWEIGHERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
7.3.6 RFID READERS 114
7.3.6.1 Rfid readers offer benefits such as reduced data entry errors and easier tracking of pharmaceutical drugs and medical devices 114
TABLE 45 RFID READERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 115
7.4 STANDALONE PLATFORMS 115
7.4.1 INCREASING ADOPTION OF FULLY INTEGRATED PLATFORMS WITH AUTOMATED FORMAT ADJUSTMENT IS DRIVING GROWTH IN THIS SEGMENT 115
TABLE 46 STANDALONE PLATFORMS OFFERED BY KEY MARKET PLAYERS 116
TABLE 47 STANDALONE PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 117
8 TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION 118
8.1 INTRODUCTION 119
TABLE 48 TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 119
 
8.2 SERIALIZATION SOLUTIONS 119
TABLE 49 SERIALIZATION SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 120
TABLE 50 SERIALIZATION SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 120
8.2.1 CARTON SERIALIZATION 121
8.2.1.1 Mandates for the implementation of serialization solutions to secure supply chain drive the market 121
TABLE 51 CARTON SERIALIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
8.2.2 BOTTLE SERIALIZATION 122
8.2.2.1 Implementation of serialization solutions in India and the US will boost the growth of the market 122
TABLE 52 BOTTLE SERIALIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
8.2.3 MEDICAL DEVICE SERIALIZATION 123
8.2.3.1 Increasing number of product recalls are driving the medical device serialization market 123
TABLE 53 MEDICAL DEVICE SERIALIZATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 123
8.2.4 BLISTER SERIALIZATION 124
8.2.4.1 Advantages of blister packaging are fueling the growth of this segment 124
TABLE 54 BLISTER SERIALIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 124
8.2.5 VIAL AND AMPOULE SERIALIZATION 125
8.2.5.1 Increasing demand for serialization at the primary packaging level is driving the growth of this segment 125
TABLE 55 VIAL AND AMPOULE SERIALIZATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 125
8.3 AGGREGATION SOLUTIONS 126
TABLE 56 REGULATORY STANDARDS FOR AGGREGATION SOLUTIONS AT VARIOUS PACKAGING LEVELS 126
TABLE 57 AGGREGATION SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 58 AGGREGATION SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 127
8.3.1 CASE AGGREGATION 127
8.3.1.1 Rising need for track and trace capabilities throughout the supply chain driving this segment 127
TABLE 59 CASE AGGREGATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 128
8.3.2 PALLET AGGREGATION 128
8.3.2.1 Rising demand for pallet aggregation for brand protection is fueling the growth of the market 128
TABLE 60 PALLET AGGREGATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 129
8.3.3 BUNDLE AGGREGATION 129
8.3.3.1 Rising awareness of secure packaging and regulatory mandates have contributed to market growth 129
TABLE 61 BUNDLE AGGREGATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
 
8.4 TRACKING, TRACING & REPORTING 130
8.4.1 REGULATORY VIGILANCE HAS DRIVEN THE DEMAND FOR TRACKING, TRACING, AND REPORTING SOLUTIONS 130
TABLE 62 TRACKING, TRACING & REPORTING SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 131
9 TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY 132
9.1 INTRODUCTION 133
TABLE 63 TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 133
9.2 2D BARCODES 133
9.2.1 ADVANTAGES ASSOCIATED WITH 2D BARCODES TO DRIVE THIS SEGMENT 133
TABLE 64 2D BARCODES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 134
9.3 RADIOFREQUENCY IDENTIFICATION (RFID) 135
9.3.1 INCREASING ADOPTION OF RFID TECHNOLOGY IN MEDICAL DEVICES AND COSMETIC PRODUCTS DISTRIBUTION DRIVES THE MARKET 135
TABLE 65 RFID MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 135
9.4 LINEAR BARCODES 136
9.4.1 HIGH ADOPTION IN CHINA AND OTHER ASIA PACIFIC COUNTRIES DRIVING MARKET GROWTH 136
TABLE 66 LINEAR BARCODES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
10 TRACK AND TRACE SOLUTIONS MARKET, BY END USER 137
10.1 INTRODUCTION 138
TABLE 67 TRACK AND TRACE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 138
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 138
10.2.1 REGULATORY MANDATES ARE IN PLACE FOR THE IMPLEMENTATION OF SERIALIZATION IN PHARMACEUTICAL SUPPLY CHAINS 138
TABLE 68 TRACK AND TRACE SOLUTIONS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION) 139
10.3 FOOD INDUSTRY 140
10.3.1 GROWING HEALTH CONCERNS ARE SUPPORTING THE INCREASED ADOPTION OF TRACK AND TRACE SOLUTIONS IN THE FOOD INDUSTRY 140
TABLE 69 TRACK AND TRACE SOLUTIONS MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2019–2026 (USD MILLION) 141
10.4 MEDICAL DEVICE COMPANIES 142
10.4.1 MANDATES FOR SERIALIZATION AND UDI COMPLIANCE TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 142
TABLE 70 TRACK AND TRACE SOLUTIONS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 143
10.5 COSMETIC INDUSTRY 143
10.5.1 IMPLEMENTATION OF MEASURES AGAINST COUNTERFEITING TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 143
TABLE 71 TRACK AND TRACE SOLUTIONS MARKET FOR COSMETIC INDUSTRY,
BY COUNTRY, 2019–2026 (USD MILLION) 144
10.6 OTHER END USERS 145
TABLE 72 TRACK AND TRACE SOLUTIONS MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 145
11 TRACK AND TRACE SOLUTIONS MARKET, BY REGION 146
11.1 INTRODUCTION 147
TABLE 73 TRACK AND TRACE SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 147
11.2 NORTH AMERICA 147
FIGURE 33 NORTH AMERICA: TRACK AND TRACE SOLUTIONS MARKET SNAPSHOT 148
TABLE 74 NORTH AMERICA: TRACK AND TRACE SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 149
TABLE 75 NORTH AMERICA: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 149
TABLE 76 NORTH AMERICA: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 77 NORTH AMERICA: TRACK AND TRACE HARDWARE COMPONENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 78 NORTH AMERICA: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 150
TABLE 79 NORTH AMERICA: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 150
TABLE 80 NORTH AMERICA: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 81 NORTH AMERICA: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 82 NORTH AMERICA: TRACK AND TRACE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 151
11.2.1 US 152
11.2.1.1 The US dominates the North American track and trace solutions market 152
TABLE 83 US: KEY MACROINDICATORS 152
TABLE 84 US: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 153
TABLE 85 US: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 86 US: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 87 US: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 154
TABLE 88 US: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 154
TABLE 89 US: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 90 US: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 91 US: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 155
11.2.2 CANADA 156
11.2.2.1 Growing focus of the government on the implementation of serialization in the pharmaceutical industry to drive market growth 156
TABLE 92 CANADA: KEY MACROINDICATORS 156
TABLE 93 CANADA: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 94 CANADA: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 95 CANADA: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 96 CANADA: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 157
TABLE 97 CANADA: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 158
TABLE 98 CANADA: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 99 CANADA: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 100 CANADA: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 159
11.3 EUROPE 159
TABLE 101 EUROPE: TRACK AND TRACE SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 160
TABLE 102 EUROPE: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 160
TABLE 103 EUROPE: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 104 EUROPE: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 105 EUROPE: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 161
TABLE 106 EUROPE: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 161
TABLE 107 EUROPE: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 108 EUROPE: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 109 EUROPE: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 162
11.3.1 GERMANY 163
11.3.1.1 Germany accounted for the largest share of the European track & trace solutions market in 2020 163
TABLE 110 GERMANY: KEY MACROINDICATORS 163
TABLE 111 GERMANY: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 163
TABLE 112 GERMANY: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 113 GERMANY: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 114 GERMANY: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 164
TABLE 115 GERMANY: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 165
TABLE 116 GERMANY: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 117 GERMANY: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 118 GERMANY: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 166
11.3.2 FRANCE 166
11.3.2.1 Presence of leading pharmaceutical companies in the country to support market growth in France 166
TABLE 119 FRANCE: KEY MACROINDICATORS 166
TABLE 120 FRANCE: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 167
TABLE 121 FRANCE: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 122 FRANCE: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 123 FRANCE: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 168
TABLE 124 FRANCE: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 168
TABLE 125 FRANCE: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 126 FRANCE: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 127 FRANCE: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 169
11.3.3 ITALY 169
11.3.3.1 Growing number of counterfeit drugs to drive the adoption of track and trace solutions 169
TABLE 128 ITALY: KEY MACROINDICATORS 170
TABLE 129 ITALY: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 130 ITALY: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 131 ITALY: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 132 ITALY: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 171
TABLE 133 ITALY: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 134 ITALY: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 135 ITALY: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 136 ITALY: TRACK AND TRACE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 173
11.3.4 SWITZERLAND 173
11.3.4.1 Implementation of serialization solutions by leading pharmaceutical companies in the country to support market growth 173
TABLE 137 SWITZERLAND: KEY MACROINDICATORS 174
TABLE 138 SWITZERLAND: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 174
TABLE 139 SWITZERLAND: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 140 SWITZERLAND: TRACK AND TRACE HARDWARE COMPONENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 141 SWITZERLAND: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 175
TABLE 142 SWITZERLAND: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 175
TABLE 143 SWITZERLAND: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 144 SWITZERLAND: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 145 SWITZERLAND: TRACK AND TRACE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 176
11.3.5 UK 177
11.3.5.1 Growth in the pharmaceuticals market to drive market growth in the UK 177
TABLE 146 UK: KEY MACROINDICATORS 177
TABLE 147 UK: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 178
TABLE 148 UK: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 149 UK: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 150 UK: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 179
TABLE 151 UK: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 179
TABLE 152 UK: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 153 UK: AGGREGATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 154 UK: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 180
 
11.3.6 SPAIN 180
11.3.6.1 Growing generic drugs and medical devices markets to propel market growth 180
TABLE 155 SPAIN: KEY MACROINDICATORS 181
TABLE 156 SPAIN: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 181
TABLE 157 SPAIN: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 158 SPAIN: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 159 SPAIN: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 182
TABLE 160 SPAIN: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 183
TABLE 161 SPAIN: SERIALIZATION SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 163 SPAIN: TRACK AND TRACE SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 184
11.3.7 REST OF EUROPE 184
TABLE 164 ROE: TRACK AND TRACE SOLUTIONS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 184
TABLE 165 ROE: TRACK AND TRACE SOFTWARE SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 166 ROE: TRACK AND TRACE HARDWARE COMPONENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 167 ROE: TRACK AND TRACE SOLUTIONS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 185
TABLE 168 ROE: TRACK AND TRACE SOLUTIONS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 186
TABLE 169 ROE: SERIALIZATION SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 170 ROE: AGGREGATION SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 171 ROE: TRACK AND TRACE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 187

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127